EWA
IRMD icon

EverSource Wealth Advisors’s iRadimed IRMD Stock Holding History

EverSource Wealth Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.87K Buy
30
+7
+30% +$638 ﹤0.01% 3564
2026
Q1 		$2.21K Sell
23
-109
-83% -$10.9K ﹤0.01% 3611
2025
Q4 		$12.8K Buy
132
+65
+97% +$5.58K ﹤0.01% 2674
2025
Q3 		$4.77K Sell
67
-10
-13% -$666 ﹤0.01% 3168
2025
Q2 		$4.6K Buy
77
+53
+221% +$2.9K ﹤0.01% 3192
2025
Q1 		$1.26K Buy
24
+8
+50% +$449 ﹤0.01% 3145
2024
Q4 		$880 Buy
+16
New +$842 ﹤0.01% 3009

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EverSource Wealth Advisors's IRMD Position: Q2 2026 in Review

EverSource Wealth Advisors increased its iRadimed (IRMD) stake by 30% in Q2 2026, buying an estimated $638 and bringing the position to 30 shares worth $2.87K. The position accounts for ﹤0.01% of the portfolio, ranked #3564.

EverSource Wealth Advisors first reported a position in IRMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $12.8K in Q4 2025. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • EverSource Wealth Advisors held 30 shares of iRadimed worth $2.87K as of Q2 2026.
  • EverSource Wealth Advisors bought 7 iRadimed shares in Q2 2026, an estimated $638.
  • iRadimed made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3564 holding.
  • EverSource Wealth Advisors first reported a position in iRadimed in Q4 2024 and has held it in 7 quarters since.
  • EverSource Wealth Advisors's iRadimed position peaked at $12.8K in Q4 2025.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.